论文部分内容阅读
我国高血压患者数量庞大,据国家卫生计生委疾控局和中国高血压联盟统计报告,中国18岁以上成年人中,高血压患者超过3.3亿人,血压在正常高值的超过3亿人;有60%成年高血压患者“血压控制不理想”。在2016年刚刚颁布的《中国成人血脂异常预防指南》高血压被列为动脉粥样硬化心血管疾病最重要的危险因素,明确提出了对高血压患者的低密度脂蛋白胆固醇(LDL-C)的控制目标。在当前整合医疗资源、惠及多数患者的医疗大环境下,心血管病防治需兼顾花费和效益,长期降胆固醇治疗更需兼顾长期获益和减轻患者经济负担,选择适
The number of hypertensive patients in our country is huge. According to the statistics of the National Health and Family Planning Commission and the China Hypertension League, more than 330 million hypertensive patients and over 300 million people with high blood pressure are among the adults over the age of 18 in China. 60% of adult hypertensive patients “blood pressure control is not ideal ”. Hypertension, the most important risk factor for atherosclerotic cardiovascular disease, was recently promulgated in 2016 as a guide to prevention of dyslipidemia in Chinese adults. It is clearly proposed that low-density lipoprotein cholesterol (LDL-C) Control objectives. The current integration of medical resources, benefit most patients in the medical environment, the prevention and treatment of cardiovascular disease should take into account the cost and effectiveness of long-term cholesterol-lowering treatment should take into account the long-term benefits and reduce the financial burden on patients, the choice of appropriate